Compounds > 2-acetylaminofluorene
Page last updated: 2024-11-07

2-acetylaminofluorene and Alloxan Diabetes

2-acetylaminofluorene has been researched along with Alloxan Diabetes in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saha, BK1
Bishayee, A1
Kanjilal, NB1
Chatterjee, M1

Other Studies

1 other study available for 2-acetylaminofluorene and Alloxan Diabetes

ArticleYear
1Alpha,25-dihydroxyvitamin D3 inhibits hepatic chromosomal aberrations, DNA strand breaks and specific DNA adducts during rat hepatocarcinogenesis.
    Cellular and molecular life sciences : CMLS, 2001, Volume: 58, Issue:8

    Topics: 2-Acetylaminofluorene; Animals; Antioxidants; Carcinogenicity Tests; Carcinogens; Chromosome Aberrat

2001